Please login to the form below

lipodystrophy

This page shows the latest lipodystrophy news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: European approvals for BMS' Opdivo, Aegerion's lipodystrophy treatment, Pfizer's biosimilar and Xeljanz

Patients with lipodystrophy have previously relied on lifestyle changes and medications, like insulin injections to manage the condition’s associated complications. ... Today’s milestone marks a significant change in the way lipodystrophy is treated.

Latest news

Safety issues dampen enthusiasm for Akcea's volanesorsen

The company is upbeat about the prospects for the drug, which is also being developed for familial partial lipodystrophy (FPL), another rare disease characterised by elevated triglyceride levels.
Isis renamed Ionis to sidestep militant association

is in trials for familial chylomicronaemia syndrome and familial partial lipodystrophy.
R&D productivity takes off

lipodystrophy - now divested to Aegerion Pharmaceuticals - has been set at an eye-watering $325, 000 a year.
Sharing good diabetes practice in the NHS

In this case the judges decided that the National Severe Insulin Resistance Service, a new national clinical service for patients with severe insulin resistance and/or lipodystrophy, was a worthy winner
Nexium windfall lifts AZ in third quarter

Meanwhile, AZ also said it is selling Myalept (metreleptin), an approved drug for generalised lipodystrophy, to Aegerion Pharmaceuticals.

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

Choices, choices: the rapidly evolving HIV treatment landscape

Since the advent of ARVs, the life expectancy of HIV patients has increased to be on par with those unaffected; however, long-term side-effects associated with NRTIs include lipodystrophy, kidney